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Abstract 
Purpose: To investigate the anti-diabetic effects of red palm oil (RPO), rooibos tea extract (RTE) and 
their combination (RPO + RTE).  
Methods: Diabetes was induced by a single administration of streptozotocin (50 mg/kg) and the rats 
were treated for 49 days. The effects of these plant products on plasma glucose, serum insulin, serum 
fructosamine, glycosylated haemoglobin (HbIAC), liver enzymes in serum and liver glycolytic enzymes 
were studied using standard techniques. 
Results: The combined treatment of RPO and RTE significantly (p < 0.05) decreased the glucose 
(20.98 ± 6.46 mmol/L to 15.60 ± 5.94 mmol/L), HbIAC (16.74 ± 2.73 % to 12.41 ± 2.25 %), fructosamine 
(98.61 ± 23.35 mmol/L to 62.52 ± 28.41 mmol/L) levels  and increased insulin (0.30 ± 0.09 ng/mL to 
0.72 ± 0.21 ng/mL) levels in the diabetic rats. Similarly, the combined treatment significantly (p < 0.05) 
reduced alanine aminotransferase (ALT) in the serum of diabetic rats. RPO + RTE significantly (p < 
0.05) increased the activity of pyruvate kinase in the liver when compared with the diabetic control 
group.  
Conclusion: Combined treatment with red palm oil and rooibos shows promising beneficial effects in 
diabetic conditions of rats. Further studies on the mechanism of actions of the plant products are 
required. 
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Diabetes mellitus is a complex disorder arising 
from various causes which include dysregulated 
glucose sensing or insulin secretion, 
autoimmune-mediated β-cell destruction in type 
1 diabetes or insufficient compensation for 
peripheral insulin resistance in type 2 diabetes 
[1]. Hyperglycaemia (excessive glucose level) is 
a link between diabetes and diabetic 
complications [2] and also plays a vital role in 
increased protein glycosylation [3,4]. Elevated 
liver enzymes in serum are widespread in 
diabetic patients and this reflects the severity of 
hepatic injury [5]. 
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Red palm oil is used as cooking oil in West and 
Central Africa and it is a source of energy and 
essential fatty acids in many regions of the world 
[6].  Red palm oil contains at least 500 ppm 
carotenoids of which the majority is in the form of 
α- and β- carotene and approximately 500 ppm 
vitamin E of which the majority is in the form of 
tocotrienols [7]. Rooibos (Aspalathus linearis), a 
South African herbal tea, is made from the 
leaves and stems of the fynbos plant. Secondary 
metabolites present in fermented rooibos plant 
include single ring phenolic acids and monomeric 
flavonoids such as dihydrochalcones, 
flavanones, flavones, and flavonols [8-10].  
 
Red palm oil and rooibos are both natural plant 
products known to have various health promoting 
benefits which can largely be attributed to their 
antioxidant properties. The present study was 
designed to investigate the potential anti-diabetic 
effects of red palm oil, rooibos and their 





Plant products  
 
Fermented rooibos was supplied by Rooibos Ltd 
(Clanwilliam, South Africa) and the red palm oil 
used was Carotino palm fruit oil from Malaysia. 
Aqueous extracts of fermented rooibos tea was 
prepared by the addition of freshly boiled tap 
water to the leaves and stems (2 g/100 mL).  The 
mixture was allowed to stand for 30 min at room 
temperature, cooled, filtered and dispensed into 




Male Wistar rats (176 - 255 g) were bred and 
used at the Medical Research Council (MRC), 
Primate Unit, Tygerberg, South Africa. The study 
was conducted after obtaining Ethical Committee 
Clearance from Cape Peninsula University of 
Technology (CPUT/HAS-REC 2010/A002). All 
the animals received humane care in accordance 
to the criteria outlined in the ‘Guide for the Care 
and Use of Laboratory Animals’ prepared by the 
National Academy of Science (NAS) and 
published by the National Institute of Health 
(Publication no. 80 – 23, revised 1978). The rats 
were maintained in a temperature controlled 
room of 22 - 25 °C, humidity of 45-55 %, 12 h 
light/dark cycle and have free access to standard 
rat chow. The rats were treated by 
supplementing their diets with 2 ml red palm oil 
[11] and/ or 2 % rooibos [8] for 49 days.  
Induction of diabetes mellitus 
 
Male Wistar rats (176 - 255 g) were injected 
intramuscularly with freshly prepared STZ (50 
mg/kg body weight (Sigma Aldrich, South Africa) 
in 0.1 M citrate buffer (pH 4.5). Blood samples 
were taken from the tail tip after 72 h of STZ 
injection and glucose levels determined using an 
Accu chek glucometer. The rats showing blood 
glucose levels above 14 mmol/L were selected 




The rats were divided into five groups consisting 
of seven rats for the normal control group and 
eight rats each for the diabetic groups.  
 
Group 1 (normal control): Rats received a 
single intramuscular injection of citrate buffer and 
given tap water orally for 49 days.  
 
Group 2 (diabetic control): Diabetes was 
induced by a single intramuscular injection of 
STZ at a dose of 50 mg/kg body weight and the 
diabetic rats were given tap water for 49 days. 
 
Group 3: Diabetes was induced by a single 
intramuscular injection of STZ at a dose of 50 
mg/kg body weight and the diabetic rats were 
treated with RPO (2 ml/day) for 49 days. 
 
Group 4: Diabetes was induced by a single 
intramuscular injection of STZ at a dose of 50 
mg/kg body weight and the diabetic rats were 
treated with RTE (2 g/100 mL) for 49 days. 
 
Group 5: Diabetes was induced by a single 
intramuscular injection of STZ at a dose of 50 
mg/kg body weight and the diabetic rats were 
treated with both RPO (2 ml/day) and RTE (2 
g/100 mL) for 49 days. 
 
At the end of experimental period, overnight-
fasted rats were sacrificed and blood was 
collected from the dorsal aorta using a syringe 
into an EDTA tube for whole blood, sodium 
fluoride/potassium oxalate tube for plasma 
(glucose determination) and serum separator 
tube for serum collection. The serum and plasma 
were separated after centrifugation at 3,000 rpm 
for 15 min and then transferred into properly 
labelled vials and stored at -80 °C until the 
analysis was carried out. The liver tissues were 
excised, rinsed in saline solution, blotted on filter 
paper, weighed and stored in the freezer at -80 
°C.  
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The level of glucose was evaluated with a kit 
using a clinical chemistry analyzer (EasyRA 
Medical, USA) according manufacturer`s 
instructions.  
 
Determination of insulin, glycosylated 
haemoglobin and fructosamine  
 
Serum insulin level was determined with a rat 
insulin radioimmunoassay kit (Millipore, USA). 
The glycosylated haemoglobin (HbA1c) in whole 
blood and serum fructosamine levels were 
determined with kits (Diazyme Laboratories, 
USA) using a chemistry analyser (Vitalab 
Selectra E) according to manufacturer`s 
instructions. 
 
Liver function assay  
 
The liver function enzyme aspartate 
aminotransferase (AST), alanine aminotrans-
ferase (ALT), alkaline phosphatise (ALP) and 
gamma glutamyl transpeptidase (GGT) were 
evaluated in the serum with kits using a clinical 
chemistry analyzer (EasyRa medical, USA) 
according manufacturer`s instructions.  
 
Glycolytic enzymes assay 
 
Pyruvate kinase (PK) and glucokinase activity 
(GK) activities in the liver were determined with 
colorimetric assay kits (Bio Vision, USA) and 





Data are expressed as means (in duplicates) ± 
standard deviation (SD). Significant differences 
between mean values of different groups were 
determined by one-way analysis of variance 
(ANOVA) using MedCalc v 12.2.1 software 
(MedCalc software bvba, Belgium).  Data not 
normally distributed was log transformed and 
analyzed using Kruskal - Wallis one-way ANOVA 
on ranks hypotheses. Differences were 




Glucose, insulin, Hb1Ac and fructosamine 
 
The levels of glucose in the diabetic rats that 
were treated singly with either RPO or RTE did 
not show any significant (p > 0.05) difference in 
comparison with the STZ control group (Fig 1).  
However, the combined treatments (RPO + RTE) 
significantly (p < 0.05) reduced the glucose level 
in comparison to the STZ control group. There 
was a significant (p < 0.05) decrease in the 
insulin levels in all the diabetic rats when 
compared with the normal control group (Fig 2). 
A significant increase in insulin level was noted 
for STZ + RPO + RTE group when compared 
with the STZ control group. 
  
There was a significant (p < 0.05) increase in the 
level of Hb1Ac in all the diabetic rats when 
compared with the normal control group (Fig 3). 
Combined treatment (RPO + RTE) significantly 
(p < 0.05) decreased the Hb1Ac level when 
compared with the STZ control group while 
diabetic rats treated with either RPO or RTE 
alone did not show any significant (p > 0.05) 
difference in the levels of Hb1Ac when compared 
with the STZ control group. Fructosamine was 
significantly (p < 0.05) increased in all the 
diabetic groups when compared with the normal 
control group (Fig 2). However, treatment with 
RPO + RTE significantly (p < 0.05) reduced 





Serum ALT, AST and ALP were significantly (p < 
0.05) increased in all the diabetic groups in 
comparison to the normal control group.  There 
was a significant (p < 0.05) decrease in ALT in 
diabetic rats treated with RPO + RTE when 
compared with the STZ control group. There was 
no significant (p > 0.05) effect on ALP in diabetic 
rats treated with RPO, RTE and RPO + RTE 
when compared with the STZ control group. GGT 
was not detectable in the serum of all normal 
control and normal treated groups. Similarly, 
diabetic rats treated with RPO and RPO + RTE 
did not show the presence of GGT while it was 
found in the serum of STZ control group as well 
as the diabetic rats treated with RTE only. 
 
Glycolytic enzymes  
 
The activity of pyruvate kinase was significantly 
(p < 0.05) reduced in the STZ control group as 
well as treated diabetic groups in comparison to 
the normal control group (Table 1). Diabetic rats 
treated with RPO and RTE alone did not show 
significant (p > 0.05) increase in pyruvate kinase 
activity. The activity of pyruvate kinase in the 
diabetic rats was significantly increased by RPO 
+ RTE supplementation when compared with 
STZ control group. There was no significant (p > 
0.05) difference in the activity of glucokinase in 
all the groups (Table 1). 
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Fig 1:  Effect of RPO and/or RTE treatments on blood glucose level. All significant differences are at p < 0.05. 
STZ, streptozotocin-induced diabetes; RPO, red palm oil; RTE, rooibos tea extract; a significant difference 
between STZ control group and normal control group; b significant difference between RPO and/or RTE treated 














































Fig 2:  Effect of RPO and/or RTE treatments on insulin level. All significant differences are at p < 0.05. STZ, 
streptozotocin-induced diabetes; RPO, red palm oil; RTE, rooibos tea extract; a significant difference between 
STZ control group and normal control group; b significant  difference between RPO and/or RTE treated groups 













































Fig 3:  Effect of RPO and/or RTE treatments on the level of Hb1Ac. All significant differences are at p < 0.05. 
STZ, streptozotocin-induced diabetes; RPO, red palm oil; RTE, rooibos tea extract. a significant difference 
between STZ control group and normal control group; b significant  difference between RPO and/or RTE treated 
groups and normal control group; c significant difference between RPO and/or RTE  treated groups and STZ 
control group 
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Fig 4: The effects of RPO and / or RTE treatments on the level of fructosamine. All significant differences are at p 
< 0.05. STZ, streptozotocin-induced diabetes; RPO, red palm oil; RTE, rooibos tea extract; a significant difference 
between STZ control group and normal control group; b significant  difference between RPO and /or RTE treated 
groups and normal control group; c significant difference between RPO and/or RTE  treated groups and STZ 
control group 
 
Table 1: Effects of RPO, RTE and RPO + RTE treatments on liver function and glycolytic enzymes 
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All significant differences are at p < 0.05. STZ, streptozotocin-induced diabetes; RPO, red palm oil; RTE, rooibos 
tea extract; AST,aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; GGT, 
gamma glutamyl transpeptidase.  a significant difference between STZ control group and normal control group. b 
significant  difference between RPO and /or RTE treated groups and normal control group. c represents 




It has been suggested that experimental animal 
models are one of the best ways to understand 
the pathophysiology of any disease [12-14]. In 
this study, the intra-muscular administration of 
streptozotocin effectively induced diabetes 
mellitus in rats which was confirmed by elevated 
levels of blood glucose. The biological effects of 
STZ may be ascribed to its hydrophilicity, 
structural similarity with glucose and alkylation 
[14]. Administration of RPO and RTE alone to the 
animals did not prevent loss of body weight in 
STZ-diabetic rats. However, the combined 
treatment with RPO + RTE was able to increase 
the body weight when compared with the STZ 
control group. From our results, the increased 
levels of plasma glucose in the diabetic rats 
treated with RPO and RTE alone were not 
significantly different from the diabetic control 
group.  
 
However, there was a significant reduction in 
glucose level in the diabetic rats with the 
combined treatment (RPO + RTE). Similarly, 
RPO + RTE significantly increased insulin level 
in the diabetic rats in comparison to the diabetic 
group. Our results reveal the anti-hyperglycaemic 
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effects of RPO + RTE which could be as a result 
of an increased responsiveness of tissues to 
insulin or increased release of insulin and 
possibly due to regeneration of islets of 
Langerhans in the pancreas.  
 
Elevated serum glucose levels have been shown 
to stimulate the synthesis of advanced glycation 
end products (AGE products) and this leads to 
the continuous induction of oxidative stress as 
well as an increasing production of reactive 
oxygen species (ROS) [15,16]. Excess blood 
glucose during the course of diabetes reacts with 
haemoglobin to form glycosylated haemoglobin 
[17]. Administration of RPO and RTE individually 
to diabetic rats showed no significant reduction in 
the glycosylated haemoglobin levels. However, 
the combined treatment with RPO and RTE 
significantly reduced the glycosylated 
haemoglobin level indicating an improvement in 
glycaemic control following their administration. 
This shows anti-hyperglycaemic activity since the 
reduced level of HbA1c corresponds to decrease 
in blood glucose level in the diabetic rats treated 
with the combined therapy (RPO + RTE). A 
significant increase in the levels of fructosamine 
in all the diabetic groups was also observed. 
However, RPO+RTE significantly decreased 
fructosamine level while there was no significant 
reduction in the levels of fructosamine in the 
diabetic rats fed with RPO and RTE alone.  
 
The liver plays a vital role in carbohydrate 
metabolism regulation and liver function tests are 
frequently used in clinical practice to screen for 
liver disease, monitor the progression of known 
disease, and monitor the effects of potentially 
hepatotoxic drugs [5]. Serum aminotransferases 
such as ALT indicates the concentration of 
intracellular hepatic enzymes that have seeped 
out into circulation which serves as a marker of 
hepatocyte injury [18]. Alanine aminotransferase 
(ALT) and aspartate aminotransferase (AST) 
activities are used as the indicators of 
hepatocytes damage [19,20].  Primarily, ALT is 
mainly found in the liver but AST can be found in 
the liver and some other organs, so it is a less-
specific marker for liver toxicity [19,20]. Our 
results showed elevated levels of AST, ALT, 
ALP, and GGT in the serum of the diabetic rats.  
 
The combined treatment (RPO + RTE) was able 
to reduce the level of ALT significantly in the 
diabetic rats. This reduction in ALT reveals the 
potential benefits of combined RPO + RTE 
treatment in the prevention of liver injury and this 
reduction could be as a result of the antioxidant 
properties of the combined RPO and RTE. The 
gamma-glutamyl transpeptidase (GGT), another 
liver enzyme acts as a marker of biliary function 
and cholestasis [18]. From our results, GGT was 
found in the serum of the diabetic rats and the 
fact that it could not be detected in the diabetic 
rats treated with RPO suggests that RPO was 
able to prevent liver damage by the non-leakage 
of GGT into the serum. 
 
In the glycolytic pathway, pyruvate kinase is the 
last enzyme involved in the transfer of a 
phosphate group from phosphoenol pyruvate 
(PEP) to adenosine diphosphate (ADP), yielding 
one molecule of pyruvate and one molecule of 
adenosine triophosphate (ATP).  In this study, 
the results showed a significant decrease in the 
activity of pyruvate kinase in the STZ diabetic 
rats in comparison with the normal control rats. A 
similar decrease in the activity of pyruvate kinase 
in diabetes has been reported following induction 
of diabetes [21]. The inhibition of pyruvate kinase 
will prevent the conversion of phosphoenol 
pyruvate to pyruvate and hence, the metabolite is 
converted back to glucose in a series of 
gluconeogenesis reactions.  
 
Based on the results, diabetic rats treated with 
either RPO or RTE did not show any significant 
difference while those treated with the 
combination of RPO + RTE showed a significant 
increase in the activity of pyruvate kinase when 
compared with the STZ control group. 
Glucokinase is an enzyme catalyzing the 
phosphorylation of glucose and other hexoses by 
means of phosphoryl donors (ATP, ADP, and 
inorganic polyphosphate) and related 
homologously and by evolution to at least three 
other hexokinases [22]. Glucokinase in the liver 
is an essential regulator of glucose storage and 
disposal [23,24] and its activity was decreased in 
the liver of diabetic rats which may be due to a 
deficiency of insulin [24]. In this study, 
glucokinase was not altered in the STZ induced 
diabetic rats. It has been previously reported that 
glucokinase, which plays a role in the generation 
of a metabolic signal for glucose induced 
secretion of insulin, is not actively involved in 




The results indicate that continuous 
administration of antioxidant compounds of plant 
origin play a complementary role in the 
management of metabolic diseases such as 
diabetes mellitus. The combined treatments of 
red palm oil and rooibos was able to show more 
significant beneficial effects in the management 
of diabetes and this may be due to the 
combination of different antioxidants (both fat 
soluble and water soluble) that are present in the 
two plant products. Further studies are 
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recommended to establish the mechanism of 
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